moderna 股份在醫療會議上的積極評價中上漲近 7%
Moderna Shares Jump Almost 7% on Positive Remarks at Healthcare Conference
Moderna Shares Jump Almost 7% on Positive Remarks
at Healthcare Conference
Along with Friday's rise, shares in the last two trading sessions have gained 11%; however, this year they are down almost 60% as the demand for COVID-19 vaccines declines.$Moderna (MRNA.US)$ shares are up almost 7% on Friday, following optimistic remarks made by a senior executive at a healthcare conference about the company's pipeline and financial position.
$Moderna (MRNA.US)$ 週五，股票上漲近7%，因一位高管在醫療會議上對公司的產品線和財務狀況發表了樂觀的評論。
Lavina Talukdar, Moderna's head of investor relations, shared at the Jefferies London Healthcare Conference on Thursday that the Cambridge, Mass.-based company expects its revenue to support its business by 2028.
Moderna投資者關係負責人Lavina Talukdar在週四的Jefferies倫敦醫療大會上分享，位於馬薩諸塞州劍橋的公司預計到2028年其營業收入將支持其業務。
"We expect to end the year with $9 billion in cash," Talukdar said, according to a transcript provided by AlphaSense. "Our investment rate ... is declining each year going forward. And we anticipate that $9 billion will have us launching 10 products over the next three years that will start to contribute to revenue a year after approval."
"我們預計年底時現金將達到$90億，"Talukdar根據AlphaSense提供的記錄說。"我們的投資率……每年都在下降。我們預計$90億將在接下來的三年內推出10個產品，這些產品將在獲得批准後的一年開始對營業收入產生貢獻。"
Along with Friday's rise, shares in the last two trading sessions have gained 11%; however, this year they are down almost 60% as the demand for COVID-19 vaccines declines.
除了週五的漲幅外，最近兩個交易日股票漲幅已達11%；然而，今年它們下跌近60%，因爲對新冠疫苗的需求在減少。
資訊熱榜
更新時間